StockData
Nuvation Bio Inc. logo

Nuvation Bio Inc. (NUVB) stock

NUVBNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 4/30101% above fair value
$3.81+0.03 (+0.79%)

Close on Nov 19, 2026Market cap $1.34BP/E –Yield –

Nuvation Bio free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

No free cash flow figures for Nuvation Bio

Nuvation Bio has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Nuvation Bio figures

See a number that looks wrong?